These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 30697366)

  • 1. Update on biomarkers of glycemic control.
    Krhač M; Lovrenčić MV
    World J Diabetes; 2019 Jan; 10(1):1-15. PubMed ID: 30697366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of different glycemic control metrics for optimizing management of diabetes.
    Kohnert KD; Heinke P; Vogt L; Salzsieder E
    World J Diabetes; 2015 Feb; 6(1):17-29. PubMed ID: 25685275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications and pitfalls of hemoglobin A1C and alternative methods of glycemic monitoring.
    Lundholm MD; Emanuele MA; Ashraf A; Nadeem S
    J Diabetes Complications; 2020 Aug; 34(8):107585. PubMed ID: 32553575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does Preoperative Glycemic Control Restore Immune Defense Against Implant-related Infection in Mice With Diabetes?
    Lin J; Huang T; Wei H; Bao B; Gao T; Zheng X; Zhu H
    Clin Orthop Relat Res; 2022 May; 480(5):1008-1017. PubMed ID: 34797251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing glycemia in diabetes using self-monitoring blood glucose and hemoglobin A1c.
    Saudek CD; Derr RL; Kalyani RR
    JAMA; 2006 Apr; 295(14):1688-97. PubMed ID: 16609091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternate glycemic markers reflect glycemic variability in continuous glucose monitoring in youth with prediabetes and type 2 diabetes.
    Chan CL; Pyle L; Kelsey MM; Newnes L; Baumgartner A; Zeitler PS; Nadeau KJ
    Pediatr Diabetes; 2017 Nov; 18(7):629-636. PubMed ID: 27873436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Indicators of glycemic control --hemoglobin A1c (HbA1c), glycated albumin (GA), and 1,5-anhydroglucitol (1,5-AG)].
    Sato A
    Rinsho Byori; 2014 Jan; 62(1):45-52. PubMed ID: 24724426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond HbA1c.
    Bloomgarden Z
    J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous Glucose Monitoring and Use of Alternative Markers To Assess Glycemia in Chronic Kidney Disease.
    Zelnick LR; Batacchi ZO; Ahmad I; Dighe A; Little RR; Trence DL; Hirsch IB; de Boer IH
    Diabetes Care; 2020 Oct; 43(10):2379-2387. PubMed ID: 32788282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of glycated albumin (GA) and GA/HbA1c ratio for diagnosis of diabetes and glycemic control: A comprehensive review.
    Yazdanpanah S; Rabiee M; Tahriri M; Abdolrahim M; Rajab A; Jazayeri HE; Tayebi L
    Crit Rev Clin Lab Sci; 2017 Jun; 54(4):219-232. PubMed ID: 28393586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for type 2 diabetes and prediabetes in obese youth: evaluating alternate markers of glycemia - 1,5-anhydroglucitol, fructosamine, and glycated albumin.
    Chan CL; Pyle L; Kelsey M; Newnes L; Zeitler PS; Nadeau KJ
    Pediatr Diabetes; 2016 May; 17(3):206-11. PubMed ID: 25652226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative biomarkers for assessing glycemic control in diabetes: fructosamine, glycated albumin, and 1,5-anhydroglucitol.
    Lee JE
    Ann Pediatr Endocrinol Metab; 2015 Jun; 20(2):74-8. PubMed ID: 26191510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How does CKD affect HbA1c?
    Bloomgarden Z; Handelsman Y
    J Diabetes; 2018 Apr; 10(4):270. PubMed ID: 29124865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes mellitus in chronic kidney disease: Biomarkers beyond HbA1c to estimate glycemic control and diabetes-dependent morbidity and mortality.
    Copur S; Onal EM; Afsar B; Ortiz A; van Raalte DH; Cherney DZ; Rossing P; Kanbay M
    J Diabetes Complications; 2020 Nov; 34(11):107707. PubMed ID: 32861562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of fructosamine and HbA1c for home self-monitoring blood glucose levels in type 2 diabetes.
    Chen HS; Chen RL; Chang ZY; Li HD
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Apr; 65(4):151-5. PubMed ID: 12135193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemoglobin A
    Chan CL; Hope E; Thurston J; Vigers T; Pyle L; Zeitler PS; Nadeau KJ
    Diabetes Care; 2018 Jul; 41(7):1406-1413. PubMed ID: 29674323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma 1,5-anhydroglucitol concentration in patients with end-stage renal disease with and without diabetes mellitus.
    Emoto M; Tabata T; Inoue T; Nishizawa Y; Morii H
    Nephron; 1992; 61(2):181-6. PubMed ID: 1630543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond self-monitored plasma glucose and HbA1c: the role of non-traditional glycaemic markers in gestational diabetes mellitus.
    Mendes N; Tavares Ribeiro R; Serrano F
    J Obstet Gynaecol; 2018 Aug; 38(6):762-769. PubMed ID: 29620435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Assessment of the Utility of Serum Fructosamine in the Diagnosis and Monitoring of Diabetes Mellitus.
    John J; Sakarde A; Chafle J; Amle D; Jose J; Sakhare V; Rathod BD
    Cureus; 2023 Jan; 15(1):e33549. PubMed ID: 36779109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of complementary markers in assessing glycaemic control in people with diabetic kidney disease undergoing iron or erythropoietin treatment.
    Konya J; Ng JM; Cox H; Cooke M; Lewis N; Bhandari S; Atkin SL; Kilpatrick ES
    Diabet Med; 2013 Oct; 30(10):1250-4. PubMed ID: 23758176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.